Entera Bio (ENTX) Competitor Comparison
We are evaluating the key criteria listed to compare Entera Bio (ENTX) against its competitors in the Biotechnology industry.
Market Capitalization
309 / 368Gross Profits
150 / 278Total Revenue
283 / 300EBITDA
59 / 337Free Cashflow
59 / 352Quick Ratio
236 / 357Earnings per Share
62 / 359Dividend yield
0 / 6Total Cash
331 / 358Performance 3 years
181 / 368Performance 5 years
156 / 368Performance 10 years
198 / 368Linearity 3 years
149 / 368Linearity 5 years
64 / 368Linearity 10 years
179 / 368Total Rank
117 / 368Dividend Rank
120 / 368Valuation Rank
301 / 368Piotroski Rank
232 / 368Muliplier Rank
339 / 368Dividend Rank - ENTX ranking 120 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.